Kernal Biologics

Onco-selective mRNA therapeutics company developing in vivo cell therapies through targeted delivery and selective translation for cancer and autoimmune diseases.

VisitClaim or join

Founded: 2016
Headquarters: Boston, MA, USA
Company size: Not disclosed
Products tracked: 2

Products by Kernal Biologics

2 products

mRNA 2.0 PlatformmRNA therapeutics platform that is intelligently programmed and selectively translated, using AI models to ensure selective translation in target cells and enabling scalable in...0.00 reviewsDrug Discovery & Biotech

T-Cell-Targeted LNPs for In Situ CAR T ProgrammingT-Cell-Targeted LNPs (lipid nanoparticles) for in situ CAR T programming, enabling targeted delivery to T-cells for in vivo CAR-T therapy generation.0.00 reviewsDrug Discovery & Biotech

Pricing for Kernal Biologics

Contact sales

Contact Kernal Biologics for current plans, volume pricing, and enterprise terms.

Trust profile

Security and compliance

No compliance claims have been published for this company.